Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Queensland Health
McKinsey
Teva
Federal Trade Commission
QuintilesIMS
Baxter
Novartis
Daiichi Sankyo
Fish and Richardson

Generated: February 17, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 077154

« Back to Dashboard

NDA 077154 describes FENTANYL-75, which is a drug marketed by 3m Drug Delivery, Actavis Labs Ut Inc, Aveva, Lavipharm Labs, Mayne Pharma, Mylan Technologies, Noven, and Specgx Llc, and is included in eight NDAs. It is available from seventeen suppliers. Additional details are available on the FENTANYL-75 profile page.

The generic ingredient in FENTANYL-75 is fentanyl. There are thirty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the fentanyl profile page.
Summary for 077154
Tradename:FENTANYL-75
Applicant:Specgx Llc
Ingredient:fentanyl
Patents:0
Therapeutic Class:Analgesics
Formulation / Manufacturing:see details
Pharmacology for NDA: 077154
Mechanism of ActionFull Opioid Agonists
Medical Subject Heading (MeSH) Categories for 077154
Suppliers and Packaging for NDA: 077154
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
FENTANYL-100 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 077154 ANDA Mallinckrodt, Inc. 0406-9000 N 0406-9000-76
FENTANYL-100 fentanyl FILM, EXTENDED RELEASE;TRANSDERMAL 077154 ANDA Mallinckrodt, Inc. 0406-9012 N 0406-9012-76

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength25MCG/HR
Approval Date:Feb 9, 2011TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength50MCG/HR
Approval Date:Feb 9, 2011TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:FILM, EXTENDED RELEASE;TRANSDERMALStrength75MCG/HR
Approval Date:Feb 9, 2011TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Covington
Farmers Insurance
Daiichi Sankyo
Fish and Richardson
Moodys
Boehringer Ingelheim
Deloitte
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot